Antonio Espinosa

3.9k total citations
147 papers, 3.0k citations indexed

About

Antonio Espinosa is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Antonio Espinosa has authored 147 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 53 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Antonio Espinosa's work include Cancer therapeutics and mechanisms (24 papers), Synthesis and biological activity (16 papers) and Synthesis and Biological Evaluation (13 papers). Antonio Espinosa is often cited by papers focused on Cancer therapeutics and mechanisms (24 papers), Synthesis and biological activity (16 papers) and Synthesis and Biological Evaluation (13 papers). Antonio Espinosa collaborates with scholars based in Spain, Italy and United Kingdom. Antonio Espinosa's co-authors include Miguel Á. Gallo, Joaquín M. Campos Rosa, Antonio Entrena, Germaine Escames, Juan Carlos Moure, Darío Acuña‐Castroviejo, Ana Conejo‐García, Josefa León, Encarnación Camacho and María Dora Carriòn and has published in prestigious journals such as Angewandte Chemie International Edition, Bioinformatics and Oncogene.

In The Last Decade

Antonio Espinosa

142 papers receiving 2.9k citations

Peers

Antonio Espinosa
Jon Chambers United Kingdom
Suk‐Ho Lee South Korea
John W. Davies Switzerland
J. J. Wright United States
Stephan C. Schürer United States
Anindya Bhattacharya United States
Xiaoyong Yang United States
Antonio Espinosa
Citations per year, relative to Antonio Espinosa Antonio Espinosa (= 1×) peers István Szatmári

Countries citing papers authored by Antonio Espinosa

Since Specialization
Citations

This map shows the geographic impact of Antonio Espinosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Espinosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Espinosa more than expected).

Fields of papers citing papers by Antonio Espinosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Espinosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Espinosa. The network helps show where Antonio Espinosa may publish in the future.

Co-authorship network of co-authors of Antonio Espinosa

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Espinosa. A scholar is included among the top collaborators of Antonio Espinosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Espinosa. Antonio Espinosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aragonés, X., Jordi Carrabina, Antonio Espinosa, et al.. (2025). Microcredentials for Open Hardware and HPC Workforce Development: The Openchip Approach with RISC-V Ecosystem. Lirias (KU Leuven). 416–423.
2.
Margalef, Tomàs, et al.. (2025). Edge computing driven forest fire spread simulation: An energy-aware study. Journal of Computational Science. 88. 102605–102605. 1 indexed citations
3.
Espinosa, Antonio, et al.. (2023). WFA-GPU: gap-affine pairwise read-alignment using GPUs. Bioinformatics. 39(12). 13 indexed citations
5.
Rubio‐Ruíz, Belén, Guiomar Pérez‐Moreno, Antonio Espinosa, et al.. (2014). In vitro antiplasmodial and cytotoxic activities of asymmetrical pyridinium derivatives. European Journal of Medicinal Chemistry. 85. 289–292. 6 indexed citations
6.
Cerquides, Jesús, et al.. (2013). Optimizing Performance for Coalition Structure Generation Problems' IDP Algorithm. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 3 indexed citations
7.
Cara, M, Pablo Ríos‐Marco, Marı́a P. Carrasco, et al.. (2013). New non-symmetrical choline kinase inhibitors. Bioorganic & Medicinal Chemistry. 21(22). 7146–7154. 14 indexed citations
8.
Acuña‐Castroviejo, Darío, Vı́ctor Tapias, Luís C. López, et al.. (2011). Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Brain Research Bulletin. 85(3-4). 133–140. 15 indexed citations
9.
Tapias, Vı́ctor, Germaine Escames, Luís C. López, et al.. (2009). Melatonin and its brain metabolite N1‐acetyl‐5‐methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. Journal of Neuroscience Research. 87(13). 3002–3010. 92 indexed citations
10.
Villatoro, María José Pineda de las Infantas y, María Dora Carriòn, M. Encarnación Camacho, et al.. (2009). NMR and conformational studies of new 5‐phenylpyrrole‐carboxamide derivatives. Magnetic Resonance in Chemistry. 47(12). 1101–1109. 2 indexed citations
11.
Díaz‐Gavilán, Mónica, José A. Gómez-Vidal, Fernando Rodríguez‐Serrano, et al.. (2008). Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies. Bioorganic & Medicinal Chemistry Letters. 18(4). 1457–1460. 31 indexed citations
12.
Carriòn, María Dora, M. Encarnación Camacho, Miguel Á. Gallo, et al.. (2008). 1H, 13C NMR, X‐ray and conformational studies of new 1‐alkyl‐3‐benzoyl‐pyrazole and 1‐alkyl‐3‐benzoyl‐pyrazoline derivatives. Magnetic Resonance in Chemistry. 46(9). 878–885. 2 indexed citations
13.
Unciti‐Broceta, Asier, María José Pineda de las Infantas y Villatoro, Miguel Á. Gallo, & Antonio Espinosa. (2006). Reduction of Different Electron‐Poor N‐Heteroarylhydrazines in Strong Basic Conditions. Chemistry - A European Journal. 13(6). 1754–1762. 14 indexed citations
14.
Espinosa, Antonio, Juan Antonio Marchal, Antonia Aránega, et al.. (2005). Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation. Il Farmaco. 60(2). 91–97. 9 indexed citations
15.
Baraldi, Pier Giovanni, Italo Beria, Paolo Cozzi, et al.. (2004). Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. Bioorganic & Medicinal Chemistry. 12(14). 3911–3921. 34 indexed citations
16.
Rosa, Joaquín M. Campos, Marvin J. Núñez, Ana Conejo‐García, et al.. (2003). QSAR-Derived Choline Kinase Inhibitors: How Rational can Antiproliferative Drug Design Be?. Current Medicinal Chemistry. 10(13). 1095–1112. 28 indexed citations
17.
Romagnoli, Romeo, Alberto Martínez, Antonio Espinosa, et al.. (2001). Design, synthesis and biological activity of 5-fluorouracil-distamycin hybrids. Medicinal Chemistry Research. 10(6). 390–403. 6 indexed citations
18.
Marchal, Juan Antonio, Consolación Melguizo, José Prados, et al.. (2000). Modulation of Myogenic Differentiation in a Human Rhabdomyosarcoma Cell Line by a New Derivative of 5‐Fluorouracil (QF‐3602). Japanese Journal of Cancer Research. 91(9). 934–940. 8 indexed citations
19.
Rosa, Joaquín M. Campos, et al.. (2000). QSAR of 1,1′-(1,2-ethylenebisbenzyl)bis(4-substitutedpyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design. Bioorganic & Medicinal Chemistry Letters. 10(8). 767–770. 28 indexed citations
20.
León, Josefa, Manuel Macı́as, Germaine Escames, et al.. (2000). Structure-Related Inhibition of Calmodulin-Dependent Neuronal Nitric-Oxide Synthase Activity by Melatonin and Synthetic Kynurenines. Molecular Pharmacology. 58(5). 967–975. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026